Evidence map›Paper›PMID 33472597›Full record

ArticleBMC genomics2021

Systematic comparison of high-throughput single-cell RNA-seq methods for immune cell profiling.

Tracy M Yamawaki, Daniel R Lu, Daniel C Ellwanger, Dev Bhatt, Paolo Manzanillo, Vanessa Arias, Hong Zhou, Oh Kyu Yoon, Oliver Homann, Songli Wang and 1 more

Abstract read
In one paragraph

Article in BMC genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tracy M Yamawaki *Genome Analysis Unit, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Daniel R Lu *Genome Analysis Unit, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Daniel C EllwangerGenome Analysis Unit, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Dev BhattOncology/Inflammation, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, United States.
Paolo ManzanilloOncology/Inflammation, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, United States.
Vanessa AriasGenome Analysis Unit, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Hong ZhouGenome Analysis Unit, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Oh Kyu YoonGenome Analysis Unit, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Oliver HomannGenome Analysis Unit, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Songli WangGenome Analysis Unit, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Chi-Ming LiGenome Analysis Unit, Amgen Research, 1120 Veterans Blvd, South San Francisco, CA, 94080, USA. CHIMINGL@amgen.com.ORCID http://orcid.org/0000-0002-2740-5652

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElucidation of immune populations with single-cell RNA-seq has greatly benefited the field of immunology by deepening the characterization of immune heterogeneity and leading to the discovery of new subtypes. However, single-cell methods inherently suffer from limitations in the recovery of complete transcriptomes due to the prevalence of cellular and transcriptional dropout events. This issue is often compounded by limited sample availability and limited prior knowledge of heterogeneity, which can confound data interpretation.

resultsHere, we systematically benchmarked seven high-throughput single-cell RNA-seq methods. We prepared 21 libraries under identical conditions of a defined mixture of two human and two murine lymphocyte cell lines, simulating heterogeneity across immune-cell types and cell sizes. We evaluated methods by their cell recovery rate, library efficiency, sensitivity, and ability to recover expression signatures for each cell type. We observed higher mRNA detection sensitivity with the 10x Genomics 5' v1 and 3' v3 methods. We demonstrate that these methods have fewer dropout events, which facilitates the identification of differentially-expressed genes and improves the concordance of single-cell profiles to immune bulk RNA-seq signatures.

conclusionOverall, our characterization of immune cell mixtures provides useful metrics, which can guide selection of a high-throughput single-cell RNA-seq method for profiling more complex immune-cell heterogeneity usually found in vivo.

Indexed as

Gene Expression ProfilingSingle-Cell AnalysisAnimalsHigh-Throughput Nucleotide SequencingHumansMiceRNA-SeqSequence Analysis, RNATranscriptomeHigh throughput sequencingImmune-cell profilingSingle cellSingle-cell RNA-seqTranscriptomics

Identifiers

PMID33472597
PMCPMC7818754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.